Reuters David Tepper’s Appaloosa went big on pharma stocks in the fourth quarter. The fund took big new positions in Teva ($ 183 million), Pfizer ($ 156 million), and Mylan ($ 125 million) in the final three months of the year, according to a 13F filing. They were the fund’s biggest new positions in the period. In addition, […]
